Viatris (VTRS) Other Accumulated Expenses (2019 - 2026)

Viatris' (VTRS) quarterly Other Accumulated Expenses came in at $3.1 billion in Q1 2026, down 13.77% year-on-year from $3.6 billion in Q1 2025, and down 4.66% quarter-over-quarter from $3.3 billion in Q4 2025.

Viatris (VTRS) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

Viatris' Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $3.1 billion for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses fell 13.77% year-over-year to $3.1 billion in Q1 2026; TTM through Mar 2026 was $3.1 billion, a 13.77% decrease from a year earlier, with the FY2025 full-year figure at $3.3 billion, down 11.86% from the prior year.
  • Other Accumulated Expenses slipped to $3.1 billion in Q1 2026 per VTRS's latest filing, from $3.3 billion in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $4.4 billion in Q1 2022 and bottomed at $3.0 billion in Q2 2023.
  • The 5-year median for Other Accumulated Expenses is $3.4 billion (2022), against an average of $3.5 billion.
  • Across the five-year window, Other Accumulated Expenses declined 27.87% in 2023 and advanced 16.27% in 2024, its largest moves.
  • Year by year, Other Accumulated Expenses stood at $3.4 billion in 2022, then decreased by 1.37% to $3.4 billion in 2023, then advanced by 9.75% to $3.7 billion in 2024, then slipped by 11.86% to $3.3 billion in 2025, then decreased by 4.66% to $3.1 billion in 2026.
  • Per Business Quant, the three latest VTRS Other Accumulated Expenses figures stand at $3.1 billion (Q1 2026), $3.3 billion (Q4 2025), and $3.6 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.13 Bn
Dec 31, 2025 3.28 Bn
Sep 30, 2025 3.62 Bn
Jun 30, 2025 3.67 Bn
Mar 31, 2025 3.63 Bn
Dec 31, 2024 3.72 Bn
Sep 30, 2024 3.86 Bn
Jun 30, 2024 3.23 Bn
Mar 31, 2024 3.28 Bn
Dec 31, 2023 3.39 Bn
Sep 30, 2023 3.32 Bn
Jun 30, 2023 3.05 Bn
Mar 31, 2023 3.19 Bn
Dec 31, 2022 3.44 Bn
Sep 30, 2022 3.50 Bn
Jun 30, 2022 3.81 Bn
Mar 31, 2022 4.43 Bn
Dec 31, 2021 4.62 Bn
Sep 30, 2021 4.63 Bn
Jun 30, 2021 4.21 Bn